Providers say claims have been reversed without notice or explanation for 340B-purchased drugs that CVS Specialty dispensed to BCBS FEP participants.

Exclusive: 340B Entities Report Unannounced and Unexplained Claims Reversals Involving CVS and Blue Cross Blue Shield

UPDATE Wednesday, June 22, 2022, 2:50 p.m. EDT—CVS Health issued this statement: “We do not comment on specific PBM client contract terms. Our clients are sophisticated purchasers, and we work closely with them to customize a benefit design meeting their specific requirements. We support the 340B drug discount program and its role in helping vulnerable populations access critical medications.


Hospitals and health centers say claims dating back to Jan. 1 have been reversed without notice or explanation this month for 340B-purchased drugs that CVS Specialty dispensed under contract pharmacy arrangements to participants in the Blue Cross and Blue Shield Federal Employee Program (FEP).

Hospitals and health centers say claims dating back to Jan. 1 have been reversed without notice or explanation this month for 340B-purchased drugs that CVS Specialty dispensed under contract pharmacy arrangements to participants in the Blue Cross and Blue Shield Federal Employee Program (FEP).

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report